News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gene Bridges GmbH Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd. (Japan)


5/26/2009 9:42:43 AM

HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd. of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET recombination technology from Gene Bridges.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES